Ad is loading...
MSIBX
Price
$16.60
Change
+$0.02 (+0.12%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

MSIBX vs VTSNX

Header iconMSIBX vs VTSNX Comparison
Open Charts MSIBX vs VTSNXBanner chart's image
Morgan Stanley Inst Passport ovrs eq A
Price$16.60
Change+$0.02 (+0.12%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
MSIBX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSIBX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSIBX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. MSIBX (142M). VTSNX pays higher dividends than MSIBX: VTSNX (3.29) vs MSIBX (1.25). MSIBX was incepted earlier than VTSNX: MSIBX (29 years) vs VTSNX (14 years). MSIBX is a more actively managed with annual turnover of: 14.00 vs. VTSNX (4.00). MSIBX has a lower initial minimum investment than VTSNX: MSIBX (1000) vs VTSNX (5000000). MSIBX annual gain was more profitable for investors over the last year : 12.84 vs. VTSNX (10.92). MSIBX return over 5 years is better than : 20.29 vs. VTSNX (15.91).
MSIBXVTSNXMSIBX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years14 years-
Gain YTD8.0034.535176%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets142M442B0%
Annual Yield % from dividends1.253.2938%
Returns for 1 year12.8410.92118%
Returns for 3 years-19.69-5.86336%
Returns for 5 years20.2915.91127%
Returns for 10 years30.9829.81104%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals